Peptide Insights
Deep dives into synthesis science, stability protocols, and the latest research on peptide compounds — written by our research team.
How Much Do Peptides Cost? 25 Sizes, Priced Per Milligram
We priced all 25 vial sizes we sell, per vial and per milligram. The spread runs 725x, and vial size explains less of it than you would think.
Read Article
GHK-Cu vs BPC-157, Seven Reviews and Zero Experiments
Seven reviews put GHK-Cu and BPC-157 side by side and no experiment has ever given both. Twelve model families mapped, graded where each literature actually stops.
KPV vs BPC-157 and the Comparison No Study Has Run
Of seventeen model families, only mouse colitis has been used for both KPV and BPC-157, and never in one experiment. An evidence-graded head-to-head.
Retatrutide vs Tirzepatide and Why the Numbers Differ
Retatrutide and tirzepatide have never been compared in a completed trial. Matched on the same estimand the gap is 5.8 points, not the 7.4 usually quoted.
Do Peptides Show Up on Drug Tests? Panels Compared
No workplace, DOT or routine military panel lists a peptide analyte. Anti-doping is a separate system with separate rules, and this explains both.
KPV: Where the Research Stops
KPV peptide has a well mapped mechanism and no completed human trials. Where the evidence ends and speculation starts, graded claim by claim.
GLOW: The Ratio Nobody Can Verify
Four sellers publish six conflicting component splits for the GLOW peptide blend. PrimeTime BioLabs publishes none, and no source can verify a ratio.
Storing Peptides Without Stability Data
Approved labels carry real storage windows. Those windows stop at the label. Here is what the evidence establishes about peptide storage, and what it does not.
Wolverine: Two Peptides, One Study
Two peptides in one vial, graded against the single controlled study that tested them together and a label that leaves the ratio undisclosed.
IGF-1 LR3: No Human Trials, No Half-Life
Ninety published records, zero human trials, and two half-life figures with no measurement behind either. An evidence-graded account of IGF-1 LR3.
Semax: FDA Said No, the Panel Said Yes
An evidence-graded Semax review. What the molecule is, what rodent and human studies found, and where it stands with the FDA after the July 2026 vote.
Thymosin Alpha-1: One Trial, Two Answers
Thymosin alpha-1 (thymalfasin) graded trial by trial. What the TESTS sepsis trial found, what Cochrane concluded on hepatitis B, and the December 2024 FDA vote.
PT-141: The Label vs the Hype
The approved label puts MC1R first, says the mechanism is unknown, and reports a 40% dropout rate. An evidence-graded look at what the PT-141 trials actually measured.
Cagrilintide Trial by Trial and What REDEFINE Actually Showed
Cagrilintide's REDEFINE results are quoted badly almost everywhere. What each trial actually found, why 20.4% and 22.7% are both correct, and where the evidence stops.
The Semaglutide Evidence File From STEP 1 to SURMOUNT-5
Four semaglutide weight-loss figures circulate, all accurate and all different. An evidence-graded walk through the trials, and which number to quote.
The Tesamorelin Evidence File
An evidence-graded tesamorelin explainer built from the FDA prescribing information and the primary trial record. Trial-by-trial grading, the adjudicated Phase 3 figures, antibody and discontinuation data, and what the evidence does not prove.
MOTS-c and the Mitochondrial Exercise Signal
What the research on MOTS-c, a mitochondrial-derived peptide, actually establishes, and what stays preclinical, unproven in humans or regulatory guesswork.
What AHK-Cu Actually Is and How It Compares to GHK-Cu
AHK-Cu rests on a single published study. What that evidence shows, what it cannot establish, and how it honestly compares to GHK-Cu.
Tirzepatide Evidence Graded Trial by Trial and Compared With Semaglutide
What the tirzepatide trials establish, graded study by study, and how it compares with semaglutide on directly comparable evidence.
The Retatrutide File: Mechanism, TRIUMPH Evidence, and the Road to FDA Review
Retatrutide (LY3437943) is Eli Lilly's investigational GIP, GLP-1 and glucagon triple agonist. What the TRIUMPH trials found, and why it is not FDA approved.
DSIP Peptide: What the Research Shows
What is DSIP peptide? The research graded study by study, the July 2026 FDA vote on Emideltide, and what the evidence does not show. Research use only.
Are Peptides Legal? US Law in 2026
What research use only means legally, what the FDA changed in 2026, and where each major peptide stands under the 503A category system.
Epitalon Peptide: What the Research Actually Shows (2026)
Epitalon peptide explained: telomere and sleep research, evidence-graded benefits, side effects, and the July 2026 FDA panel vote that changed its status.
What Is KLOW Peptide? What the Research Actually Shows
An evidence-graded look at KLOW peptide: what each of the four components shows in research, why the blend itself is untested, and how to read its COA.
NAD+ Benefits: What the Research Actually Shows
A benefit-by-benefit verdict on NAD+ benefits, graded against human trials, covering the peptide question, how NMN and NR compare, and the IV evidence gap.
What the Research Actually Shows About BPC-157 vs TB-500
BPC-157 and TB-500 compared on the evidence: different molecules, lopsided human data, and the truth about the 'Wolverine stack.' No hype, just research.
What the Research Actually Shows About GHK-Cu
GHK-Cu is a copper-bound tripeptide with a large preclinical literature and small, mixed topical human trials. Chemistry, evidence, COA checks, and FDA status.
TB-500: What Research Actually Shows
TB-500 is the seven-amino-acid fragment Ac-LKKTETQ, not full-length thymosin beta-4. Every published human trial tested the parent molecule.
BPC-157 Explained Without the Hype
BPC-157 is a 15-amino-acid research peptide first studied in Zagreb. What 190+ studies show about tendons, gut, and safety, plus the FDA's 2026 vote.
How to Choose a Research Peptide Supplier: A Due-Diligence Checklist
Five questions separate a documented research peptide supplier from a repackager, and every one is answerable before you place an order. Use this checklist on any supplier — including us.
Solid-Phase Peptide Synthesis Explained: How Research Peptides Are Made
Nearly every research peptide on the market today is built the same way: one amino acid at a time, anchored to a solid resin. Here's how SPPS actually works.
How to Read a Peptide Certificate of Analysis (COA)
A Certificate of Analysis proves a peptide batch's purity and identity — if you know how to read one. Here's what each section means and how to verify it.